6-(Bromomethyl)-2,4-pteridinediamine hydrobromide

Suppliers

Names

[ CAS No. ]:
52853-40-4

[ Name ]:
6-(Bromomethyl)-2,4-pteridinediamine hydrobromide

[Synonym ]:
6-(Bromomethyl)pteridine-2,4-diamine hydrobromide (1:1)
6-bromomethyl-2,4-pteridinediamine monohydrobromide
6-(Bromomethyl)-2,4-pteridinediamine hydrobromide
2,4-Pteridinediamine, 6-(bromomethyl)-, hydrobromide (1:1)
6-Bromomethyl-pteridine-2,4-diamine hydrobromide
6-BROMOMETHYL-PTERIDINE-2,4-DIAMINE HBR
6-(Bromomethyl)-2,4-pteridinediamine hydrobromide (1:1)
2,4-Pteridinediamine,6-(bromomethyl)-, hydrobromide (1:1)

Chemical & Physical Properties

[ Boiling Point ]:
524.7ºC at 760 mmHg

[ Melting Point ]:
>195ºC (dec.)

[ Molecular Formula ]:
C7H8Br2N6

[ Molecular Weight ]:
335.987

[ Flash Point ]:
271.1ºC

[ Exact Mass ]:
333.917694

[ PSA ]:
103.60000

[ LogP ]:
2.59960

Safety Information

[ Hazard Codes ]:
Xi

[ HS Code ]:
2933990090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • 2,4-diamino-6-(hydroxymethyl)pteridine

DownStream

  • ethyl 4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoate
  • Aminopterin
  • 4-(2-CARBOXY-1-(2,4-DIAMINOPTERIDIN-6-YL)PENT-4-YN-2-YL)BENZOIC ACID
  • 4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoicacid
  • 2,4-diamino-6-(hydroxymethyl)pteridine
  • 4-(N-[2,4-DIAMINO-6-PTERIDINYLMETHYL]-AMINO)BENZOIC ACID SODIUM SALT
  • 4-Amino-4-deoxy-10-methylpteroic acid
  • Methotrexate
  • Glycine, N-[N-[4-[[(2, 4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-.alpha.-gluta myl]-
  • diethyl 2-[[4-[2-(2,4-diaminopteridin-6-yl)ethenyl]benzoyl]amino]pentanedioate

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Related Compounds

  • 6-(bromomethyl)-2,4-diethoxyquinazoline
  • 6-(bromomethyl)-2,4-dimethoxy-5-nitropyrimidine
  • 6-(BROMOMETHYL)-2,4-DIMETHYL-5,6-DIHYDROTHIENO[2,3-D]PYRIMIDINE
  • 6-(bromomethyl)-2-[4-(bromomethyl)phenyl]-1,3-benzoxazole
  • 6-(bromomethyl)-2,4-dimethylphenanthrene
  • N,N'-(6-(bromomethyl)-2,4-quinazolinediyl)bisbenzamide
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 3-Cyclopropoxy-N,N-dimethyl-5-sulfamoylbenzamide
  • (3S,9aR)-9-Methyl-3-phenyl-9,9a-dihydro-3H-[1,2]dioxino[3,4-b]indole
  • (5-((2-(Difluoromethyl)quinazolin-4-yl)thio)-4-methyl-4H-1,2,4-triazol-3-yl)methanamine
  • 1-Benzyl-4-(2-bromo-2-methylpropanoyl)piperazine
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide